$GILD Recent Headlines Long view on stocks is best

New Post Public Reply Private Reply Replies (0) Message Board

Apr 21, 2014 at 9:57 AM

$GILD Recent Headlines

Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
UnitedHealth already seeing effects of Gilead's pricey hepatitis C drug 5:54 p.m. April 17, 2014 - blogs.marketwatch.com
4 reasons the first quarter was better than it appeared 6:20 a.m. April 17, 2014 - Tim Clift
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 4:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 4:36 p.m. April 10, 2014 - Saumya Vaishampayan
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - blogs.marketwatch.com
Merck: Hepatitis C drug has 98% cure rate in trial 11:43 a.m. April 10, 2014 - MarketWatch.com
Toss these investments as part of spring cleaning 6:00 a.m. April 10, 2014 - Jeff Reeves
First Solar tops S&P 500; Alcoa up ahead of earnings 3:51 p.m. April 8, 2014 - Ben Eisen
Gilead hepatitis C drug to get FDA priority review 9:40 a.m. April 7, 2014 - MarketWatch.com
Gilead: Hepatitis C Japan trial meets endpoint 3:43 a.m. April 3, 2014 - MarketWatch.com
Facebook, Biogen, Cal-Maine are stocks to watch 5:21 a.m. March 31, 2014 - Victor Reklaitis
Play-it-safe stock investors may take some risk on jobs 8:30 a.m. March 30, 2014 - Wallace Witkowski
U.S. stocks end week with losses 7:17 p.m. March 28, 2014 - Anora Mahmudova
Bombora watch, the 'momo' chart of pain and 5 reasons to buy Citigroup 8:33 a.m. March 28, 2014 - blogs.marketwatch.com
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - blogs.marketwatch.com
Nasdaq slumps 1.2%, but Dow dips just 0.2%: Stock market live blog recap 3:39 p.m. March 24, 2014 - blogs.marketwatch.com
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - blogs.marketwatch.com
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - blogs.marketwatch.com

J.P. Morgan’s Top Biotech and Health Care Picks With Huge Upside 8:39 a.m. Today - 247WallSt.com
Weekly Insider Sells Highlight: ATHN, GILD, JPM, WAG 10:06 p.m. April 20, 2014 - GuruFocus.com
Excellent Earnings, Tough Audience, Surprises Among the Leaders: Jim Cramer's Best Blogs 6:00 a.m. April 19, 2014 - TheStreet.com
Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings 11:12 a.m. April 18, 2014 - Investors Business Daily
UnitedHealth Earnings Drop on ObamaCare, Medicare Cuts 5:13 p.m. April 17, 2014 - Investors Business Daily
Has A Streamlined FDA Raised The Value Of Drug Stocks? 4:33 p.m. April 17, 2014 - Investors Business Daily
After Shaky Start, Weibo Jumps in Nasdaq Debut 4:00 p.m. April 17, 2014 - FOXBusiness
Today's Top Performers In Drugs 1:03 p.m. April 17, 2014 - TheStreet.com
UnitedHealth's Profit Falls Amid Health-Law Changes 11:33 a.m. April 17, 2014 - The Wall Street Journal Interactive Edition
Managers See Buys in Choppy Markets, Including Gilead, LinkedIn 9:41 a.m. April 17, 2014 - TheStreet.com
Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings 9:18 a.m. April 17, 2014 - TheStreet.com
Ready For A Rebound? Gilead's $1000 Pill 7:38 a.m. April 17, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ALXN MRK GILD XRAY 7:30 a.m. April 17, 2014 - InvestorPlace.com
Rolling The Dice With Earnings 5:29 p.m. April 16, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: EBAY, GS, GILD 3:14 p.m. April 16, 2014 - TheStreet.com
Gilead Sciences May See A Healthy Earnings Beat 1:35 p.m. April 16, 2014 - Seeking Alpha
IPOs: 4 Stocks To Buy After The Plunge 10:08 a.m. April 16, 2014 - InvestorPlace.com
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog 10:07 a.m. April 16, 2014 - Zacks.com
Why Gilead Sciences Inc. (GILD) Stock Might be a Great Pick - Tale of the Tape 8:32 a.m. April 16, 2014 - Zacks.com
3 Pharmaceuticals to Profit on Obamacare 6:34 a.m. April 16, 2014 - InvestorPlace.com

Young Scientists From Around the State Will Compete for Top Honors at the 63rd California State Science Fair 6:31 p.m. April 16, 2014 - PR Newswire - PRF
Gilead Sciences to Release First Quarter 2014 Financial Results on Tuesday, April 22, 2014 5:00 p.m. April 15, 2014 - BusinessWire - BZX
AHF: Anti-Gilead Drug Pricing Campaign Picks Up Steam 2:24 p.m. April 14, 2014 - BusinessWire - BZX
Financial Release Dates -- Research on Gilead Sciences, Juniper Networks, FirstCommonwealth Financial, and Genuine Parts 9:00 a.m. April 14, 2014 - PR Newswire - PRF
Final Data from the Phase 2 COSMOS Study of Janssen’s Once-Daily Simeprevir in Combination with Sofosbuvir Presented at the International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL) 11:24 a.m. April 12, 2014 - BusinessWire - BZX
Final Data from the Phase 2 COSMOS Study of Janssen's Once-Daily Simeprevir in Combination with Sofosbuvir Presented at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL) 11:15 a.m. April 12, 2014 - PR Newswire - PRF
Final Data from the Phase 2 COSMOS Study of Janssen's Once-Daily Simeprevir in Combination with Sofosbuvir Presented at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL) 11:15 a.m. April 12, 2014 - PR Newswire - PRF
Priority Reviews, Preliminary Earnings Releases, Clinical Trials Results, and Launch of Website - Analyst Notes on Gilead, Pfizer, Intuitive Surgical, Alkermes and Quest 10:14 a.m. April 11, 2014 - PR Newswire - PRF
Today's Review on Active Stocks -- Research on Ashford Hospitality Trust, Dejour Energy, North American Palladium, and Gilead Sciences 1:30 p.m. April 10, 2014 - PR Newswire - PRF
Emerging Therapies in Development for Relapsed/Refractory CLL/SLL are Expected to Offer Efficacy Benefits Over Currently Available Treatments 10:00 a.m. April 10, 2014 - PR Newswire - PRF
Gilead Announces Phase 2 Results for Two Investigational All-Oral Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C 1:02 a.m. April 10, 2014 - BusinessWire - BZX
Clinical Trial Results Presentation and Publication, and Upcoming Exhibit - Analyst Notes on Gilead Sciences, Agios, Mindray, BG Medicine, and Ultragenyx 8:00 a.m. April 9, 2014 - PR Newswire - PRF
Gilead Announces U.S. FDA Priority Review Designation for Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Chronic Hepatitis C Genotype 1 Infection 8:31 a.m. April 7, 2014 - BusinessWire - BZX
Senior Notes Conversions, FDA Drug Approvals, Acquisitions, Stock Price Updates, and Clinical Trial Studies - Analyst Notes on Gilead, Pfizer, Nordion, Intuitive Surgical, and Novartis 8:00 a.m. April 3, 2014 - PR Newswire - PRF
Gilead Announces Results From Phase 3 Study of Sofosbuvir Among Hepatitis C Patients in Japan 4:30 p.m. April 2, 2014 - BusinessWire - BZX
Critical Alerts For Ford, Castlight Health, Gilead Sciences, Take Two Interactive, and Qihoo 360 Released By InvestorsObserver 9:31 a.m. April 2, 2014 - PR Newswire - PRF
Pending Applications, Closed Public Offering, Joint Venture Formation, Executive Appointment, and Commercial Launch - Analyst Notes on Gilead, Enzymotec, Intrexon, Advaxis, and Repligen 8:00 a.m. April 1, 2014 - PR Newswire - PRF
Comprehensive Technical Coverage on Active Equities -- Research on Sirius XM, Gilead Sciences, Microsoft, and Yahoo! 12:03 p.m. March 31, 2014 - PR Newswire - PRF
Gilead Announces Settlement Method for 1.00% Convertible Senior Notes Due 2014 8:30 a.m. March 28, 2014 - BusinessWire - BZX
Gilead's Marketing Application Validated by EMA; Accenture Misses Zack's Consensus Estimate 12:38 a.m. March 28, 2014 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fast Guard Elevates Nationwide Fire Watch Mission

Fast Guard: The Unseen Shield Behind Property Safety Hollywood, Florida might be best known for its sun-kissed beaches, but in the world of fire safety, it’s the nerve center for emergency fire watch response. Fast Guard Service isn’t just any run-of-the-mill security outfit; it’s rapidly becoming the unsung hero of property managers across the nation. When those...

Tragedy Highlights Need for E-bike Safety Overhaul

A Dire Wake-Up Call in the East Village We're staring hard at a heartbreaking mess in the East Village. A 15-year-old girl lost her life while riding an electric Citi Bike, hit by an industrial truck. Let's not dance around it—this is a gut punch, the kind you never want to ever hear about, and one that comes with a bitter flavor of 'what if?' Age Verification: A...

Qatar Foundation Spurs Sport-Driven Empowerment Moves

Here we go, diving into the serious talk of the moment: sports pushing boundaries to uplift society's underdogs. Envision yourself in the halls of Wilton Park, where the thinkers, the dreamers, and the doers convened in the name of change. Qatar Foundation ain't just sitting pretty; they're championing the cause to harness sport for impactful social threads across the...

PayPal Under Investigation: Legal Battles Intensify

A Bumpy Ride for PayPal's Investors Back in 2025, PayPal was beaming about new growth strategies, filling the air with grandiose promises. Fast forward to February 2026, and the script had flipped entirely. Earnings came in nasty and disappointing, particularly in the Branded Checkout front. Adding to the chaos was their CEO unceremoniously taking the high road out the...

USPS Rolls Out Christmas Cookie Stamps Nationwide

USPS Delivers Nostalgia with Cookie-Themed Stamps Let's talk stamps, folks. The U.S. Postal Service has rolled out its newest Christmas Cookies Forever stamps, bringing a dash of sugary nostalgia to mailboxes nationwide. The release was celebrated at the Smithsonian National Postal Museum, spotlighting a tradition as sweet as the sugar cookies themselves. These aren't...

Med Spa Visits: Key Insights from Lindsey Smith

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

2026 Lantern Festival Shines in Kunshan Amid Tensions

Lanterns Illuminate Cross-Strait Relations Under the shadow of geopolitical tensions, the 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival kicked off with a splash on September 16. Held in Kunshan, Suzhou, this cultural festival offers a rare glimpse of cooperation and shared cultural celebration across the Taiwan Strait. Through lantern displays, art exhibitions,...

China's Tech Success Echoes in Global Living Rooms

A New Player in Global Tech If you've been sleeping on China's tech scene, it's time to wake up. Moonshot AI just launched Kimi K3, the largest open-source model by parameters we've seen, a significant leap in artificial intelligence that's catching even the eyes of folks who hardly touch technology—like retirees in Italy. Rapid AI Advancements China's story isn't about...

BarrelPick.com Launches for Bourbon Aficionados

Just when you think you've seen all the ways to enjoy bourbon, along comes BarrelPick.com with a tantalizing new proposition. They're throwing down the gauntlet for bourbon lovers everywhere by letting you buy an entire barrel, let it sit around for a bit, watch it mature, and then call the shots on when it finally sees the light of day in a bottle. Talk about skipping...

Insta360 Expands with Times Square Flagship Store

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...